Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Whitley

Showing results (471-480 of 489) with videos related to

Pageof 49
Sort By:
The Journal of Infectious Diseases|December 12, 2018
Blood Viral Load in Symptomatic Congenital Cytomegalovirus InfectionConcetta Marsico, Immaculada Aban, Huichien Kuo, et al.
Infection Control and Hospital Epidemiology|October 9, 2010
Moving toward elimination of healthcare-associated infections: a call to actionDenise Cardo, Penelope H Dennehy, Paul Halverson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2014
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responsesJames M Markert, Shantanu N Razdan, Hui-Chien Kuo, et al.
Blood Cells, Molecules & Diseases|July 30, 2018
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trialPierluigi Tricoci, Megan Neely, Michael J Whitley, et al.
The Journal of Infectious Diseases|May 1, 1997
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupR J Whitley, G Cloud, W Gruber, et al.
Oncoimmunology|November 20, 2019
A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibitionJoshua D Bernstock, Nunzio Vicario, Li Rong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2015
Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir TherapyJohn W Gnann, Birgit Sköldenberg, John Hart, et al.
Archives of Internal Medicine|May 20, 1998
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USAR J Whitley, M A Jacobson, D N Friedberg, et al.
The Pediatric Infectious Disease Journal|December 2, 2009
Safety of oseltamivir compared with the adamantanes in children less than 12 months of ageDavid W Kimberlin, Marwan Shalabi, Mark J Abzug, et al.
Current Biology : CB|September 3, 2021
Nectar-feeding bats and birds show parallel molecular adaptations in sugar metabolism enzymesJoshua H T Potter, Rosie Drinkwater, Kalina T J Davies, et al.
Pageof 49

Showing results (471-480 of 489) with videos related to

Sort By:
Pageof 49
The Journal of Infectious Diseases|December 12, 2018
Blood Viral Load in Symptomatic Congenital Cytomegalovirus InfectionConcetta Marsico, Immaculada Aban, Huichien Kuo, et al.
Infection Control and Hospital Epidemiology|October 9, 2010
Moving toward elimination of healthcare-associated infections: a call to actionDenise Cardo, Penelope H Dennehy, Paul Halverson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2014
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responsesJames M Markert, Shantanu N Razdan, Hui-Chien Kuo, et al.
Blood Cells, Molecules & Diseases|July 30, 2018
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trialPierluigi Tricoci, Megan Neely, Michael J Whitley, et al.
The Journal of Infectious Diseases|May 1, 1997
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupR J Whitley, G Cloud, W Gruber, et al.
Oncoimmunology|November 20, 2019
A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibitionJoshua D Bernstock, Nunzio Vicario, Li Rong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2015
Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir TherapyJohn W Gnann, Birgit Sköldenberg, John Hart, et al.
Archives of Internal Medicine|May 20, 1998
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USAR J Whitley, M A Jacobson, D N Friedberg, et al.
The Pediatric Infectious Disease Journal|December 2, 2009
Safety of oseltamivir compared with the adamantanes in children less than 12 months of ageDavid W Kimberlin, Marwan Shalabi, Mark J Abzug, et al.
Current Biology : CB|September 3, 2021
Nectar-feeding bats and birds show parallel molecular adaptations in sugar metabolism enzymesJoshua H T Potter, Rosie Drinkwater, Kalina T J Davies, et al.
Pageof 49